(19)
(11) EP 1 021 538 A1

(12)

(43) Date of publication:
26.07.2000 Bulletin 2000/30

(21) Application number: 98952143.0

(22) Date of filing: 07.10.1998
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/31, C12N 15/62, C12N 1/19, C07K 14/47, C07K 14/395, C12Q 1/02, C12Q 1/68, G01N 33/50
(86) International application number:
PCT/US9821/168
(87) International publication number:
WO 9918/211 (15.04.1999 Gazette 1999/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.10.1997 US 946298

(71) Applicant: CADUS PHARMACEUTICAL CORPORATION
Tarrytown, NY 10591-6705 (US)

(72) Inventors:
  • BROACH, James, R.
    Princeton, NJ 08540 (US)
  • MANFREDI, John, P.
    Ossining, NY 10562 (US)
  • PAUL, Jeremy, I.
    Nyack, NY 10690 (US)
  • TRUEHEART, Joshua
    South Nyack, NY 10960 (US)
  • KLEIN, Christine, A.
    Ossining, NY 10562 (US)
  • MURPHY, Andrew, J., M.
    Montclair, NJ 07043 (US)
  • XU, Jun
    Ossining, NY 10562 (US)
  • BENEGAL, Anupama, N.
    River Edge, NJ 07661 (US)

(74) Representative: Hutchins, Michael Richard et al
FRY HEATH & SPENCEThe Old College53 High Street
HorleySurrey RH6 7BN
HorleySurrey RH6 7BN (GB)

   


(54) YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR